SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-002189
Filing Date
2023-02-08
Accepted
2023-02-08 17:02:23
Documents
15
Period of Report
2023-02-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lbph-20230207.htm   iXBRL 8-K 72088
2 EX-1.1 lbph-ex1_1.htm EX-1.1 390119
3 EX-5.1 lbph-ex5_1.htm EX-5.1 24574
4 GRAPHIC img207609832_0.jpg GRAPHIC 55819
  Complete submission text file 0000950170-23-002189.txt   758319

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lbph-20230207.xsd EX-101.SCH 2495
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lbph-20230207_pre.xml EX-101.PRE 12053
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lbph-20230207_lab.xml EX-101.LAB 18448
9 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20230207_htm.xml XML 5112
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40192 | Film No.: 23599945
SIC: 2834 Pharmaceutical Preparations